Yoon M, Park JJ, Greenberg B. Finerenone and polypharmacy in heart failure with mildly reduced or preserved ejection fraction: a marker of risk, not a barrier to therapy. Eur J Heart Fail 2026 Feb 10:xuag025. doi: 10.1093.
PMID: 41771105